Expression of MAGE genes in osteosarcoma

Journal of Orthopaedic Research

Volumn 15, Issue 1, 1997, Pages 128-132

  Sudo, T ^a   Kuramoto, T ^a   Komiya, S ^a   Inoue, A ^a   Itoh, K ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BIOCOMPATIBILITY; BONE; DISEASES; ORTHOPEDICS; PROTEINS; RNA; TISSUE;

GENE EXPRESSION; HISTOCOMPATIBILITY; LYMPHOCYTES; MELANOMA ANTIGEN GENES; OSTEOSARCOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

GENES;

HLA ANTIGEN CLASS 1; MELANOMA ANTIGEN; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; OSTEOSARCOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR REJECTION;

EID: 0031039554     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100150119     Document Type: Article

References (18)

1. 1 De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora J‐P, De Smet C, Brasseur F, Van Der Bruggen P, Lethe B, Lurquin C, Brasseur R, Chomez P, De Backer O, Cavenee W, Boon T: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360–369, 1994
2. 2 De Smet C, Lurquin C, Vander Bruggen P, De plaen E, Brasseur F, Boon T: Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 39: 121–129, 1994
3. 3 Gaugler B, Van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethe B, Brasseur F, Boon T: Human gene MAGE‐3 codes for an antigen recognized on a melanoma by autologous cytolytic Tlymphocytes. J Exp Med 179: 921–930, 1994
4. 4 Goorin AM, Andersen JW: Experience with multiagent chemotherapy for osteosarcoma: improproved outcome. Clin Orthop 270: 22–28, 1991
5. 5 Hoshion T, Yamada A, Honda J, Imai Y, Nakao M, Inoue M, Sagawa K, Yokoyama M, Oizumi K, Itoh K: Tissue‐specific distribution and age‐dependent increase of human CD11b + T cells. J Immunol 151: 2237–2246, 1993
6. 6 Link Mp, Goorin AM, Horowitz M, Meyer WH, Belasco J, Baker A, Ayala A, Shuster J: Adjuvant chemotherapy of highgrade osteosarcoma of the extremity: updated results of the multi‐institutional osteosarcoma study. Clin Orthop 270: 8–14 1991
7. 7 Marchand M, Weynants P, Rankin E, Arienti F, Belli F, Parmiani G, Cascinelli N, Bourlond A, Vanwijck R, Humblet Y Canon J‐L, Laurent C, Naeyaert J‐M, Plagne R, Deraemaeker R, Knuth A, Jäuger E, Brasseur F, Herman J, Coulie PG, Boon T: Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE‐3. Int J Cancer 63: 883–885, 1995
8. 8 Rock KL: A new foreign Policy: MHC class I molecules monitor the outside world. Immunol Today 17: 131–137, 1996
9. 9 Rosen G, Marcove R, Caparros B, Nirenberg A, Koslfoo C, Huvos AG: Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer 43: 2163–2177, 1979
10. 10 Shichijo S, Hayashi A, Takamori S, Tsunosue R, Hoshino T, Sakata M, Kuramoto T, Oizumi K Itoh K: Detection of MAGE‐4 protein in lung cancers. Int J Cancer 64: 158–165, 1995
11. 11 Shichijo S, Tsunosue R, Kubo K, Kuramoto T, Tanaka Y, Hayashi A, Itoh K: Establishment of an enzyme‐linked immunosorbent assay (ELISA) for measuring cellular MAGE‐4 protein on human cancers. J Immunol Methods 186: 137–149, 1995
12. 12 Shichijo S, Sagawas K, Brasseur F, Boon T, Itoh K: MAGE‐1 gene is expressed inT‐cell leukemia. Int J Cancer 65: 709–710, 1996
13. 13 Takahashi Km Shichijo S, Noguchi M, Hirohata M, Itoh K: Indentification of MAGE‐1 and MAGE‐4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 55: 3478–3482, 1995
14. 14 Travesari C, van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar‐Costesec A, Boon T: A nonapeptide encoded by human gene MAGE‐1 is recognized on HLA‐A1 by cytolytic T lymphocytes directed against tumor antigen MZ2‐E. J Exp Med 176: 1453–1457, 1992
15. 15 van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T: A gene encoding an antiger recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643–1647, 1991
16. 16 van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boel P, De Smet C, Traversari C, Townsend A, Boon T: A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3. Eur J Immunol 24: 3038–3043, 1994
17. 17 van der Bruggen P, Szikora J‐P, Boel P, Wildmann C, Somville M, Sensi M, Boon T: Autolgous cytolytic T lymphocytes recognize a MAGE‐1, nonapeptide on melanomas expressing HLA‐Cw*1601. Eur J Immunol 24: 2134–2140, 1994
18. 18 Yamada A, Kataoka A, Shichijo S, Kamura T, Imai Y, Nishida T, Itoh K: Expression of MAGE‐1, MAGE‐2, MAGE‐3/‐6 and MAGE‐4a/‐4b genes in ovarian tumors. Int J Cancer 64: 388–393, 1995